Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters










Publication year range
1.
Neuropharmacology ; 111: 293-303, 2016 12.
Article in English | MEDLINE | ID: mdl-27618742

ABSTRACT

Multiple sclerosis (MS) is a neurodegenerative disease characterized by episodes of immune attacks and oligodendrocyte death leading to demyelination and progressive functional deficits. New therapeutic strategies are needed to stimulate the spontaneous regenerative process observed in some patients. Spontaneous myelin repair relies on the mobilization and differentiation of endogenous oligodendrocyte progenitors at the lesion site. Olesoxime, a cholesterol-like compound, has been shown to favor oligodendrocyte maturation in culture and promote myelin regeneration in rodents. Here, we study the mode of action of this compound and show that it binds to oligodendrocyte mitochondria, leading to their hyperfilamentation. This is accompanied by a reduction of basal superoxide levels, and accumulation of End Binding Protein 1 (EB1) at growing ends of microtubules. In parallel, we demonstrate that Reactive Oxygen Species (ROS) scavengers also promote oligodendrocyte differentiation, together with increasing mitochondrial filamentation and EB1-dependent microtubule polymerization. Altogether, our data uncover the mechanisms by which olesoxime promotes oligodendrocyte maturation. They also reveal that a bidirectional relationship between mitochondria hyperfilamentation and ROS level modulation controls oligodendrocyte maturation. This study identifies new cellular mechanisms to target for the development of regenerative treatments for MS.


Subject(s)
Cell Differentiation/drug effects , Cholestenones/pharmacology , Microtubules/drug effects , Mitochondria/drug effects , Oligodendroglia/drug effects , Animals , Cells, Cultured , Cholestenones/therapeutic use , Microtubule-Associated Proteins/metabolism , Microtubules/metabolism , Mitochondria/metabolism , Multiple Sclerosis/metabolism , Multiple Sclerosis/prevention & control , Myelin Basic Protein/metabolism , Neocortex/drug effects , Neocortex/metabolism , Oligodendroglia/physiology , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Superoxides/metabolism
2.
Neurobiol Dis ; 90: 3-19, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26494254

ABSTRACT

Mitochondria are dynamic organelles that continually move, fuse and divide. The dynamic balance of fusion and fission of mitochondria determines their morphology and allows their immediate adaptation to energetic needs, keeps mitochondria in good health by restoring or removing damaged organelles or precipitates cells in apoptosis in cases of severe defects. Mitochondrial fusion and fission are essential in mammals and their disturbances are associated with several diseases. However, while mitochondrial fusion/fission dynamics, and the proteins that control these processes, are ubiquitous, associated diseases are primarily neurological disorders. Accordingly, inactivation of the main actors of mitochondrial fusion/fission dynamics is associated with defects in neuronal development, plasticity and functioning, both ex vivo and in vivo. Here, we present the central actors of mitochondrial fusion and fission and review the role of mitochondrial dynamics in neuronal physiology and pathophysiology. Particular emphasis is placed on the three main actors of these processes i.e. DRP1,MFN1-2, and OPA1 as well as on GDAP1, a protein of the mitochondrial outer membrane preferentially expressed in neurons. This article is part of a Special Issue entitled: Mitochondria & Brain.


Subject(s)
Mitochondria/metabolism , Mitochondrial Dynamics/physiology , Neurodegenerative Diseases/metabolism , Neuronal Plasticity/physiology , Animals , Brain/metabolism , Humans , Neurons/metabolism
3.
Anal Bioanal Chem ; 389(3): 763-7, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17676313

ABSTRACT

A method for determining plasma power in rf-GDOES is presented. It is based on an effective resistance located in the inductive coil of the impedance matching. The amount of electrical power consumed in the matching system depends on the capacitive current flowing through the matching system, which depends on the applied voltage, the stray capacity, and the frequency. This correction method is experimentally evaluated and compared with the integral plasma power calculation.

4.
Anal Bioanal Chem ; 388(8): 1625-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17503024

ABSTRACT

A high-current pulsed hollow cathode discharge was used to study the role of atomic and ionic metastables involved in ionization plasma processes. We observed the enhancement of the spectral emission lines of noble gas ions in the afterglow. A study of the processes that involve atomic and ionic metastables is of great interest since it should lead to a better understanding of and enhanced control over the ionization mechanisms crucial to analytical glow discharge mass spectrometry (GDMS) analysis.

5.
Cell Death Differ ; 14(4): 682-92, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17024226

ABSTRACT

In most eucaryote cells, release of apoptotic proteins from mitochondria involves fission of the mitochondrial network and drastic remodelling of the cristae structures. The intramitochondrial dynamin OPA1, as a potential central actor of these processes, exists as eight isoforms resulting from the alternate splicing combinations of exons (Ex) 4, 4b and 5b, which functions remain undetermined. Here, we show that Ex4 that is conserved throughout evolution confers functions to OPA1 involved in the maintenance of the DeltaPsi(m) and in the fusion of the mitochondrial network. Conversely, Ex4b and Ex5b, which are vertebrate specific, define a function involved in cytochrome c release, an apoptotic process also restricted to vertebrates. The drastic changes of OPA1 variant abundance in different organs suggest that nuclear splicing can control mitochondrial dynamic fate and susceptibility to apoptosis and pathologies.


Subject(s)
Alternative Splicing/genetics , Apoptosis/physiology , GTP Phosphohydrolases/chemistry , GTP Phosphohydrolases/metabolism , HeLa Cells/metabolism , Mitochondrial Proteins/metabolism , Yeasts/metabolism , Animals , Apoptosis/genetics , Evolution, Molecular , Humans , Microscopy, Fluorescence , Mitochondrial Membranes/physiology , Protein Interaction Mapping , Protein Isoforms/genetics , Sequence Analysis, Protein , Tumor Cells, Cultured
6.
Anal Bioanal Chem ; 386(1): 163-8, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16724217

ABSTRACT

In radiofrequency glow discharge emission spectrometry (RF-GDOES), the excitation voltage used to create the plasma is applied to the back or front end of the sample to be analyzed. In this paper we focus on back-applied voltage systems (a configuration that represents about half of the instruments available on the market), and on applied voltage problems (the power coupling efficiency and materials analysis are beyond the scope of this study). In the RF-GDOES of nonconductive samples, a voltage drop develops inside the material. The voltage transfer coefficient is defined as the ratio between the peak voltage in front of the sample (facing the plasma) and the peak voltage applied to the back of the sample. In this work, we show that it is possible to increase the voltage transfer coefficient by increasing the capacitance of the sample. The capacitance of a given nonconductive material depends on its surface, its thickness and its permittivity. Increasing the voltage transfer coefficient permits higher power deposition in the plasma. This study is based on an electrical equivalent circuit for the discharge device, which takes into account the sample and reactor capacitances as well as the voltage probes used for the measurements. This circuit, when modeled by a commercial electrical circuit simulator, gives the voltage transfer coefficient as a function of the sample capacitance. Different approaches to increasing the sample capacitance and their influence on the voltage transfer coefficient are presented and related to the 750.4 nm argon line intensity, which is correlated to the electron density.

8.
Hum Genet ; 109(6): 584-91, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11810270

ABSTRACT

Optic atrophy type 1 (OPA1, MIM 165500) is a dominantly inherited optic neuropathy that features low visual acuity leading in many cases to legal blindness. We have recently shown, with others, that mutations in the OPA1 gene encoding a dynamin-related mitochondrial protein, underlie the dominant form of optic atrophy. Here we report that OPA1 has eight mRNA isoforms as a result of the alternative splicing of exon 4 and two novel exons named 4b and 5b. In addition, we screened a cohort of 19 unrelated patients with dominant optic atrophy by direct sequencing of the 30 OPA1 exons (including exons 4b and 5b) and found mutations in 17 (89%) of them of which 8 were novel. A majority of these mutations were truncative (65%) and located in exons 8 to 28, but a number of them were amino acid changes predominantly found in the GTPase domain (exons 8 to 15). We hypothesize that at least two modifications of OPA1 may lead to dominant optic atrophy, that is alteration in GTPase activity and loss of the last seven C-terminal amino acids that putatively interact with other proteins.


Subject(s)
Alternative Splicing/genetics , GTP Phosphohydrolases/genetics , Optic Atrophy, Autosomal Dominant/genetics , Amino Acid Sequence , Chromosomes, Human, Pair 3 , Exons/genetics , Frameshift Mutation , Genetic Testing/methods , Humans , Molecular Sequence Data , Mutagenesis, Insertional , Mutation, Missense , Optic Atrophy, Autosomal Dominant/etiology , Point Mutation , Polymorphism, Genetic , Sequence Deletion , Sequence Homology, Amino Acid
9.
Nat Genet ; 26(2): 207-10, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11017079

ABSTRACT

Optic atrophy type 1 (OPA1, MIM 165500) is a dominantly inherited optic neuropathy occurring in 1 in 50,000 individuals that features progressive loss in visual acuity leading, in many cases, to legal blindness. Phenotypic variations and loss of retinal ganglion cells, as found in Leber hereditary optic neuropathy (LHON), have suggested possible mitochondrial impairment. The OPA1 gene has been localized to 3q28-q29 (refs 13-19). We describe here a nuclear gene, OPA1, that maps within the candidate region and encodes a dynamin-related protein localized to mitochondria. We found four different OPA1 mutations, including frameshift and missense mutations, to segregate with the disease, demonstrating a role for mitochondria in retinal ganglion cell pathophysiology.


Subject(s)
Chromosomes, Human, Pair 3 , GTP Phosphohydrolases/genetics , Mutation , Optic Atrophy/genetics , Amino Acid Sequence , Cell Nucleus/genetics , Chromosome Mapping , Dynamins , Exons , Female , GTP Phosphohydrolases/chemistry , Genes, Dominant , Humans , In Situ Hybridization, Fluorescence , Male , Mitochondria/genetics , Molecular Sequence Data , Pedigree , Polymorphism, Genetic , Saccharomyces cerevisiae/genetics , Schizosaccharomyces/genetics , Sequence Alignment , Sequence Homology, Amino Acid
10.
J Cell Sci ; 112 ( Pt 22): 4151-61, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10547374

ABSTRACT

We recently identified Msp1p, a fission yeast Schizosaccharomyces pombe dynamin-related protein, which is essential for the maintenance of mitochondrial DNA. The Msp1p sequence displays typical features of a mitochondrial protein. Here we report in vitro and in vivo data that validate that prediction. We demonstrate that the targeting sequence of Msp1p is processed by recombinant mitochondrial processing peptidase and that Msp1p is imported into S. pombe mitochondria in vitro in the presence of cellular extracts. We show that the first 109 residues of Msp1p encompass a functional peptide signal that is sufficient to direct chimera to mitochondria. Immunofluorescence studies indicate that Msp1p staining colocalises with a mitochondrial marker and electron microscopy shows that the protein is located inside the mitochondria. Mitochondrial enrichment and fractionation further confirm that localisation and show that Msp1p is anchored to the matrix side of the mitochondrial inner membrane. Finally, we report that overexpression of the Msp1 protein results in gross alteration of the mitochondrial structure and function. All together our results suggest that Msp1p is an essential component for mitochondrial maintenance.


Subject(s)
GTP Phosphohydrolases/metabolism , Mitochondria/metabolism , Schizosaccharomyces/metabolism , Amino Acid Sequence , Biological Transport , Dynamins , Electron Transport/physiology , GTP Phosphohydrolases/chemistry , GTP Phosphohydrolases/genetics , Gene Expression Regulation, Fungal/physiology , Intracellular Membranes/metabolism , Intracellular Membranes/ultrastructure , Metalloendopeptidases/metabolism , Microscopy, Immunoelectron , Mitochondria/ultrastructure , Molecular Sequence Data , Protein Sorting Signals/chemistry , Protein Sorting Signals/physiology , Schizosaccharomyces/ultrastructure , Schizosaccharomyces pombe Proteins , Mitochondrial Processing Peptidase
11.
FEBS Lett ; 443(1): 71-4, 1999 Jan 22.
Article in English | MEDLINE | ID: mdl-9928955

ABSTRACT

The nim1/cdr1 protein kinase is required for an efficient adaptation of cell cycle parameters to changes in nutritional conditions. We have isolated msp1, a new fission yeast member of the dynamin-related large GTPase family, in a two-hybrid screen designed to identify proteins interacting with the nim1 kinase. Msp1 has been shown to be essential for the maintenance of mtDNA and hence for the inheritance of functional mitochondria. We present evidence indicating that niml and mspl proteins physically interact both in vitro and in vivo in fission yeast. These interactions occur through the amino-terminal catalytic domain of nim1 and the carboxy-terminal putative regulatory domain of mspl. These results provide new evidence for the existence of a connection between mitochondrial function and the cell cycle machinery.


Subject(s)
Fungal Proteins/metabolism , GTP Phosphohydrolases/metabolism , GTP-Binding Proteins , Mitochondrial Proteins , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Saccharomyces cerevisiae Proteins , Schizosaccharomyces pombe Proteins , Schizosaccharomyces/metabolism , Cell Cycle , Cloning, Molecular , Dynamins , Mitochondria , Protein Binding
12.
Biochem Biophys Res Commun ; 251(3): 720-6, 1998 Oct 29.
Article in English | MEDLINE | ID: mdl-9790976

ABSTRACT

Members of the dynamin-related proteins family have been identified in a wide range of organisms, however their precise functions remain elusive. We have identified a new member of that GTPase family in the fission yeast Schizosaccharomyces pombe. We show that Msp1+ is an essential nuclear gene encoding a 101 kDa protein whose closest homologue is the S. cerevisiae MGM1 gene product. We also report that msp1 conditional loss of function affects the maintenance of mitochondrial DNA and leads to growth arrest associated with respiratory deficiency.


Subject(s)
Adenosine Triphosphatases/genetics , DNA, Mitochondrial/metabolism , Fungal Proteins/genetics , GTP-Binding Proteins , Mitochondria/physiology , Mitochondrial Proteins , Saccharomyces cerevisiae Proteins , Schizosaccharomyces/physiology , Adenosine Triphosphatases/classification , Amino Acid Sequence , Dynamins , Fungal Proteins/classification , GTP Phosphohydrolases/genetics , Genes, Essential , Genes, Fungal , Molecular Sequence Data , Mutagenesis , Schizosaccharomyces pombe Proteins , Sequence Homology, Amino Acid
13.
Biochem Biophys Res Commun ; 232(1): 204-8, 1997 Mar 06.
Article in English | MEDLINE | ID: mdl-9125132

ABSTRACT

The fission yeast cdr1/nim1 protein kinase phosphorylates and inactivates the weel cdc2-inhibitory kinase. We have investigated the role played by cdr1/nim1 in the connection between nutritional signals and the cell cycle machinery. We show that loss of nim1 activity impairs the appropriate cellular adaptation to nutritional changes. However, the reduction in cell size at division in response to nitrogen starvation is independent of nim1. Moreover, we report that nim1 is an unstable protein that is rapidly degraded upon starvation, through a mechanism that is dependent upon protein synthesis. We propose that nim1, as a constitutive indirect activator of cdc2 at mitosis, favors the cellular response to starvation but does not actively participate in it. On the contrary, upon nitrogen starvation nim1 must be actively destroyed to protect the cells from a commitment into the cell cycle under unfavourable growth conditions.


Subject(s)
Cell Cycle , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Schizosaccharomyces pombe Proteins , Schizosaccharomyces/enzymology , Nitrogen , Schizosaccharomyces/cytology
14.
Yeast ; 11(3): 225-31, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7785323

ABSTRACT

The effect of phleomycin, a bleomycin-like antibiotic, has been investigated in the fission yeast, Schizosaccharomyces pombe. We report that in response to phleomycin-induced DNA damage, growth was inhibited and S. pombe cells arrested in the G2-phase of the cell cycle. DNA repair mutants rad9 and rad17 did not arrest and were hypersensitive to phleomycin. Cell cycle mutants that entered mitosis without monitoring the completion of DNA replication also displayed an increased sensitivity to this DNA-damaging agent. Thus, phleomycin could be used as a tool in the fission yeast S. pombe model system for the study of DNA damage and cell cycle checkpoints, or as a new selective agent.


Subject(s)
DNA Damage , Phleomycins/pharmacology , Schizosaccharomyces/drug effects , Cell Cycle/drug effects , Cell Division/drug effects , DNA Repair/genetics , DNA, Fungal/drug effects , DNA, Fungal/metabolism , Drug Resistance, Microbial/genetics , G2 Phase/genetics , Models, Biological , Mutation , Schizosaccharomyces/cytology , Schizosaccharomyces/metabolism
15.
Prog Cell Cycle Res ; 1: 207-14, 1995.
Article in English | MEDLINE | ID: mdl-9552364

ABSTRACT

Close connections appear to exist between extra-cellular signals that regulate cell proliferation and the protein kinases that control the cell cycle machinery. The fission yeast nim1 kinase is an inducer of cdc2 kinase activity acting through the inhibition of wee1 kinase. Nim1 function is required for a correct cellular response to nutritional starvation. In the absence of nim1, starved cells are unable to decrease their size at mitosis, to arrest their cycle in G1 and to enter G0. Here, we review our current knowledge on the role and the regulation of nim1 in connecting cell cycle and nutritional pathways.


Subject(s)
Cell Cycle Proteins , Cell Cycle , Nuclear Proteins , Protein Serine-Threonine Kinases/physiology , Protein-Tyrosine Kinases/physiology , Schizosaccharomyces pombe Proteins , Schizosaccharomyces/physiology , CDC2 Protein Kinase/metabolism , Cell Culture Techniques , Protein-Tyrosine Kinases/metabolism
16.
Biochimie ; 77(4): 279-87, 1995.
Article in English | MEDLINE | ID: mdl-8589058

ABSTRACT

Phosphotyrosyl turnover is an essential regulatory mechanism for many biological processes, and the balance between tyrosine kinases and phosphatases plays a major role in the control of cell proliferation. Phenylarsine oxide (PAO), a potent inhibitor of tyrosine phosphatases (PTPase), was used to investigate the involvement of PTPase in the growth and control of the cell cycle of the fission yeast Schizosaccharomyces pombe. Cell proliferation was arrested by treatment with PAO, which was found to inhibit cdc25 PTPase in vitro but appeared not to act in vivo on this mitosis inducer. The PAO-treated cells displayed a mono- or binucleated phenotype and a DNA content that was either 2C or 4C, indicating a cell cycle arrest with a failure to complete cytokinesis. Entry into the cell division cycle from the G0 quiescent stage was also delayed by treatment with PAO. These results suggest that a number of key events in the mitotic cell cycle are regulated by as yet unidentified PTPases.


Subject(s)
Arsenicals/pharmacology , Cell Cycle/drug effects , Enzyme Inhibitors/pharmacology , Schizosaccharomyces/drug effects , Schizosaccharomyces/physiology , Cell Division/drug effects , Cell Division/physiology , Mutation , Protein Tyrosine Phosphatases/antagonists & inhibitors , Protein Tyrosine Phosphatases/genetics , Protein Tyrosine Phosphatases/physiology , Schizosaccharomyces/genetics
17.
Cell Mol Biol Res ; 40(5-6): 547-54, 1994.
Article in English | MEDLINE | ID: mdl-7735329

ABSTRACT

Basic Fibroblast Growth Factor-2 (FGF-2) promotes G1 to S transition of quiescent sparse adult bovine aortic endothelial cells. In addition to signal transduction through interaction with tyrosine kinase high affinity receptor, FGF-2 is translocated to the nucleus and accumulated into the nucleolus. These data suggest that FGF-2 functions directly in nuclear events. In vivo, correlations were established between the entrance of FGF-2 into the nucleus and an increase in rDNA transcription and in protein phosphorylation. In vitro, in experiments carried out with nuclei isolated from quiescent cells, addition of FGF-2 increases rDNA transcription by a factor of 5 and also increases protein phosphorylation. Nucleolin, a factor involved in control of rDNA transcription is preferentially phosphorylated. It has been shown that nucleolin and other factors implicated in rDNA transcription are substrates of protein kinase CKII. Using purified kinase CKII and nucleolin in an in vitro phosphorylation assay, we have shown that FGF-2 activates the protein kinase activity. These results suggest that FGF-2 could act as an activator of rDNA transcription through interactions with the protein kinase CKII.


Subject(s)
DNA, Ribosomal/genetics , Fibroblast Growth Factor 2/pharmacology , Gene Expression Regulation/drug effects , Protein Serine-Threonine Kinases/physiology , RNA, Ribosomal/biosynthesis , RNA-Binding Proteins , Transcription, Genetic/drug effects , Animals , Aorta , Casein Kinase II , Cattle , Cell Nucleolus/metabolism , Cell Nucleus/metabolism , Cells, Cultured , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , G1 Phase/drug effects , Nuclear Proteins/metabolism , Phosphoproteins/metabolism , Phosphorylation/drug effects , Protein Processing, Post-Translational/drug effects , RNA, Ribosomal/genetics , Signal Transduction/drug effects , Stimulation, Chemical , Nucleolin
19.
Exp Cell Res ; 203(1): 259-69, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1385190

ABSTRACT

The Ag-NOR proteins are defined as markers of "active" ribosomal genes. They correspond to a set of proteins specifically located in the nucleolar organizer regions (NORs), but have not yet been clearly identified. We adapted the specific detection method of the Ag-NOR proteins to Western blots in order to identify these proteins. Using a purified protein, Western blots, and immunological characterization, the present study brings the first direct evidence leading to the identity of one Ag-NOR protein. We found that nucleolin is specifically revealed by Ag-NOR staining. Using different nucleolin fragments generated by CNBr cleavage and by overexpression in Escherichia coli, we demonstrate that the amino-terminal domain of nucleolin and not the carboxy-part of the protein is involved in silver staining. Moreover, as the pattern of staining does not vary using casein kinase II- and cdc2-phosphorylated nucleolin or dephosphorylated nucleolin, we conclude that the reduction of the silver ions is not linked to the phosphorylation state of the molecule. We propose that the concentration of acidic amino acids in the amino-terminal domain of nucleolin is responsible for Ag-NOR staining. This hypothesis is also supported by the finding that poly L-glutamic acid peptides are silver stained. These results provide data that can be used to explain the specificity of Ag-NOR staining. Furthermore, we clearly establish that proteolysis of the amino-terminal Ag-NOR-sensitive part of nucleolin occurs in vitro, leading to the accumulation of the carboxy-terminal Ag-NOR-negative part of the protein. We argue that this cleavage occurs in vivo as already proposed, bearing in mind that nucleolin is present in the fibrillar and in the granular component of the nucleolus, whereas no Ag-NOR staining is observed in the latter nucleolar component.


Subject(s)
Nuclear Proteins/metabolism , Nucleolus Organizer Region/ultrastructure , Phosphoproteins/metabolism , RNA-Binding Proteins , Amino Acid Sequence , Animals , Antigens, Nuclear , Blotting, Western , CHO Cells , Cricetinae , Electrophoresis, Polyacrylamide Gel , HeLa Cells , Humans , Molecular Sequence Data , Nuclear Proteins/analysis , Nuclear Proteins/isolation & purification , Peptides/chemical synthesis , Peptides/immunology , Phosphoproteins/analysis , Phosphoproteins/isolation & purification , Phosphorylation , Protein Kinases/metabolism , Silver , Staining and Labeling , Tumor Cells, Cultured , Nucleolin
20.
Nucleic Acids Res ; 20(19): 5053-60, 1992 Oct 11.
Article in English | MEDLINE | ID: mdl-1408821

ABSTRACT

Nucleolin, a major nucleolar protein, forms a specific complex with the genome (a single-stranded DNA molecule of minus polarity) of parvovirus MVMp in vitro. By means of South-western blotting experiments, we mapped the binding site to a 222-nucleotide motif within the non-structural transcription unit, referred to as NUBE (nucleolin-binding element). The specificity of the interaction was confirmed by competitive gel retardation assays. DNaseI and nuclease S1 probing showed that NUBE folds into a secondary structure, in agreement with a computer-assisted conformational prediction. The whole NUBE may be necessary for the interaction with nucleolin, as suggested by the failure of NUBE subfragments to bind the protein and by the nuclease footprinting experiments. The present work extends the previously reported ability of nucleolin to form a specific complex with ribosomal RNA, to a defined DNA substrate. Considering the tropism of MVMp DNA replication for host cell nucleoli, these data raise the possibility that nucleolin may contribute to the regulation of the parvoviral life-cycle.


Subject(s)
DNA, Viral/metabolism , Minute Virus of Mice/metabolism , Nuclear Proteins/metabolism , Phosphoproteins/metabolism , RNA-Binding Proteins , Base Sequence , Cell Line , Cell Nucleus/physiology , DNA, Viral/genetics , DNA, Viral/isolation & purification , Genome, Viral , Humans , Immunoblotting , Lung , Minute Virus of Mice/genetics , Models, Structural , Molecular Sequence Data , Nuclear Proteins/isolation & purification , Nucleic Acid Conformation , Phosphoproteins/isolation & purification , Nucleolin
SELECTION OF CITATIONS
SEARCH DETAIL
...